Eupraxia Pharmaceuticals logo

Eupraxia Pharmaceuticals Share Price Today

(NASDAQ: EPRX)

Eupraxia Pharmaceuticals share price is $3.08 & ₹268.25 as on 5 Feb 2025, 2.30 'hrs' IST

$3.08

0.05

(1.54%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Eupraxia Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Eupraxia Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Eupraxia Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Eupraxia Pharmaceuticals share price movements

  • Today's Low: $2.98
    Today's High: $3.10

    Day's Volatility :3.87%

  • 52 Weeks Low: $2.20
    52 Weeks High: $4.08

    52 Weeks Volatility :46.08%

Eupraxia Pharmaceuticals (EPRX) Returns

PeriodEupraxia Pharmaceuticals IncIndex (Russel 2000)
3 Months
-0.92%
0.0%
6 Months
28.87%
0.0%
1 Year
4.41%
0.0%
3 Years
4.41%
-11.7%

Eupraxia Pharmaceuticals (EPRX) Key Statistics

in dollars & INR

Previous Close
$3.0332
Open
$3.1
Today's High
$3.1
Today's Low
$2.98
Market Capitalization
$91.9M
Today's Volume
$9.4K
52 Week High
$4.08
52 Week Low
$2.2
Revenue TTM
$0.0
EBITDA
$-31.8M
Earnings Per Share (EPS)
$-0.93
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-314.41%

How to invest in Eupraxia Pharmaceuticals Stock (EPRX) from India?

It is very easy for Indian residents to invest directly in Eupraxia Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Eupraxia Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Eupraxia Pharmaceuticals or EPRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Eupraxia Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Eupraxia Pharmaceuticals shares which would translate to 0.283 fractional shares of Eupraxia Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Eupraxia Pharmaceuticals, in just a few clicks!

Returns in Eupraxia Pharmaceuticals (EPRX) for Indian investors in Rupees

The Eupraxia Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Eupraxia Pharmaceuticals investment value today

Current value as on today

₹1,09,310

Returns

₹9,310

(+9.31%)

Returns from Eupraxia Pharmaceuticals Stock

₹4,407 (+4.41%)

Dollar Returns

₹4,903 (+4.9%)

Indian investors sentiment towards Eupraxia Pharmaceuticals (EPRX)

-88%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Eupraxia Pharmaceuticals Stock from India on INDmoney has decreased by -88% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Eupraxia Pharmaceuticals

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Eupraxia Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Insights on Eupraxia Pharmaceuticals Stock (Ticker Symbol: EPRX)

  • Price Movement

    In the last 7 days, EPRX stock has moved up by 7.7%

Eupraxia Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Eupraxia Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Eupraxia Pharmaceuticals (EPRX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Eupraxia Pharmaceuticals Inc logo
2.67%
28.87%
4.41%
4.41%
4.41%
Biontech Se logo
-2.55%
47.81%
22.02%
-32.21%
279.34%
Regeneron Pharmaceuticals, Inc. logo
-2.68%
-34.72%
-25.67%
12.0%
82.54%
Vertex Pharmaceuticals Incorporated logo
19.82%
3.52%
15.9%
98.26%
100.9%
Alnylam Pharmaceuticals, Inc. logo
16.23%
4.16%
57.39%
82.31%
115.97%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Eupraxia Pharmaceuticals Inc logo
NA
NA
NA
0.0
-3.14
-0.99
NA
0.42
Biontech Se logo
160.8
NA
0.04
-3.37
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
16.49
16.49
1.08
44.92
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.21
0.48
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Eupraxia Pharmaceuticals Inc logo
Buy
$91.9M
4.41%
NA
0.0%
Biontech Se logo
Buy
$28.7B
279.34%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.3B
82.54%
16.49
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$121.1B
100.9%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$35.4B
115.97%
NA
-15.86%

About Eupraxia Pharmaceuticals

Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidates are EP-104IAR, which is in a Phase III clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis; EP-104GI, which is in a Phase II clinical trial for the treatment of eosinophilic esophagitis; and EP-104, under preclinical studies for the treatment of other inflammatory joint conditions, benign structures of the esophagus, and epidural delivery. It also is involved in the development of product candidates for oncology. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.
Organization
Eupraxia Pharmaceuticals
Employees
29
CEO
Dr. James A. Helliwell FRCPC, M.D.
Industry
Miscellaneous

Management People of Eupraxia Pharmaceuticals

NameTitle
Dr. James A. Helliwell FRCPC, M.D.
CEO & Director
Mr. Bruce G. Cousins C.A., CPA
President & CFO
Dr. Amanda Malone Ph.D.
Chief Scientific Officer & COO
Mr. Paul Anthony Brennan B.Sc., M.Sc.
Chief Business Officer
Dr. Mark M. Kowalski M.D., Ph.D.
Chief Medical Officer
Dr. Rahul Sarugaser M.B.A., Ph.D.
Executive Vice President of Corporate Development

Important FAQs about investing in EPRX Stock from India :

What is Eupraxia Pharmaceuticals share price today?

Eupraxia Pharmaceuticals share price today stands at $3.08, Open: $3.10 ; Previous Close: $3.03 ; High: $3.10 ; Low: $2.98 ; 52 Week High: $4.08 ; 52 Week Low: $2.20.

The stock opens at $3.10, after a previous close of $3.03. The stock reached a daily high of $3.10 and a low of $2.98, with a 52-week high of $4.08 and a 52-week low of $2.20.

Can Indians buy Eupraxia Pharmaceuticals shares?

Yes, Indians can invest in the Eupraxia Pharmaceuticals (EPRX) from India.

With INDmoney, you can buy Eupraxia Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Eupraxia Pharmaceuticals at zero transaction cost.

How can I buy Eupraxia Pharmaceuticals shares from India?

It is very easy to buy Eupraxia Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Eupraxia Pharmaceuticals (EPRX) be purchased?

Yes, you can buy fractional shares of Eupraxia Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Eupraxia Pharmaceuticals stocks?

To start investing in Eupraxia Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Eupraxia Pharmaceuticals Stock (EPRX)?

Today’s highest price of Eupraxia Pharmaceuticals (EPRX) is $3.10.

Today’s lowest price of Eupraxia Pharmaceuticals (EPRX) is $2.98.

What is today's market capitalisation of Eupraxia Pharmaceuticals?

Today's market capitalisation of Eupraxia Pharmaceuticals EPRX is 91.9M

What is the 52 Week High and Low Range of Eupraxia Pharmaceuticals Stock (EPRX)?

  • 52 Week High

    $4.08

  • 52 Week Low

    $2.20

What are the historical returns of Eupraxia Pharmaceuticals (EPRX)?

  • 1 Month Returns

    2.67%

  • 3 Months Returns

    28.87%

  • 1 Year Returns

    4.41%

  • 5 Years Returns

    4.41%

Who is the Chief Executive Officer (CEO) of Eupraxia Pharmaceuticals ?

Dr. James A. Helliwell FRCPC, M.D. is the current Chief Executive Officer (CEO) of Eupraxia Pharmaceuticals.